Logo wahanariau.com
  2. Aim immunotech

Aim immunotech

Index
Globenewswire

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

Kamis, 19 Maret 2026 - 04:13:18 Wib
Globenewswire

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Jumat, 26 September 2025 - 00:14:53 Wib